ANVISA vs COFEPRIS: Medical Device Regulatory Comparison
Compare the medical device registration pathways, classification, and regulatory requirements of ANVISA (Brazil) vs COFEPRIS (Mexico).
ANVISA
Agência Nacional de Vigilância Sanitária (Brazil)
Brazil
ANVISA regulates medical devices in Brazil using a four-class risk-based system. Brazil is an MDSAP participating country. ANVISA requires a Brazilian Registration Holder (BRH) for foreign manufacture…
Class I, II, III, IV
ANVISA cadastro (Class I-II) / registro (Class III-IV)
- ▸Device registration (cadastro/registro)
- ▸Brazilian Registration Holder requirement
- ▸MDSAP participation
- ▸GMP (INMETRO) certification
- ▸ANVISA Technical Opinion
COFEPRIS
Federal Commission for Protection against Health Risks (Mexico)
Mexico
COFEPRIS regulates medical devices in Mexico under the General Health Law. Mexico uses a three-class system (I, II, III). A sanitary registration (registro sanitario) is required for Class II and III …
Class I, II, III
COFEPRIS sanitary registration
- ▸Sanitary registration
- ▸FDA/EU recognition pathway
- ▸GMP compliance
- ▸Import permits
- ▸Vigilance reporting
MedFlux monitors both ANVISA and COFEPRIS in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.
COMPARE LIVE DATA FREE →